Gefitinib (Iressa) in NSCLC: A real alternative to chemotherapy

Evening Symposium
Chairs: N. Thatcher (Manchester, United Kingdom)
The importance of symptom improvement with gefitinib in NSCLC
P. J. Souquet (Pierre-Benite, France)
Slide presentation
Slide presentation